Insulet Stock Today
| PODD Stock | USD 242.72 0.02 0.01% |
PerformanceWeakest
| Odds Of DistressTiny
|
Insulet is trading at 242.72 as of the 16th of February 2026, a 0.0082% down since the beginning of the trading day. The stock's lowest day price was 241.63. Insulet has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on September 12, 2025, Representative Ro Khanna of US Congress acquired under $15k worth of Insulet's common stock.
Business Domain Health Care Equipment & Services | IPO Date 15th of May 2007 | Category Healthcare | Classification Health Care |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts. Insulet Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 70.35 M outstanding shares of which 1.93 M shares are at this time shorted by private and institutional investors with about 2.24 trading days to cover. More on Insulet
Moving together with Insulet Stock
Moving against Insulet Stock
Insulet Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | James Hollingshead | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP 500 Index, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Obamacare Repeal, Baby Boomer Prospects, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBy employing borrowed capital, Insulet can potentially magnify investment returns. Examining the debt-to-assets ratio offers investors perspective on Insulet's use of financial leverage and reveals what portion of Insulet's asset base relies on creditor financing.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Insulet (PODD) is traded on NASDAQ Exchange in USA and employs 3,900 people. Insulet is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.09 B. Insulet conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 70.35 M outstanding shares of which 1.93 M shares are at this time shorted by private and institutional investors with about 2.24 trading days to cover.
Insulet currently holds about 708.6 M in cash with 430.3 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 10.21.
Check Insulet Probability Of Bankruptcy
Ownership AllocationThe majority of Insulet outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Insulet to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Insulet. Please pay attention to any change in the institutional holdings of Insulet as this could imply that something significant has changed or is about to change at the company. On September 12, 2025, Representative Ro Khanna of US Congress acquired under $15k worth of Insulet's common stock.
Check Insulet Ownership Details
Insulet Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Fidelity International Ltd | 2025-06-30 | 1.1 M | |
| Norges Bank | 2025-06-30 | 1 M | |
| Goldman Sachs Group Inc | 2025-06-30 | 988.9 K | |
| Ubs Asset Mgmt Americas Inc | 2025-06-30 | 832.5 K | |
| Citadel Advisors Llc | 2025-06-30 | 771.5 K | |
| Federated Hermes Inc | 2025-06-30 | 723.4 K | |
| Northern Trust Corp | 2025-06-30 | 705.6 K | |
| Charles Schwab Investment Management Inc | 2025-06-30 | 681.1 K | |
| Artisan Partners Limited Partnership | 2025-06-30 | 671.5 K | |
| Vanguard Group Inc | 2025-06-30 | 8.7 M | |
| Fmr Inc | 2025-06-30 | 7.5 M |
Insulet Historical Income Statement
Insulet Stock Against Markets
Insulet Corporate Management
| Philip Hildale | Senior Care | Profile | |
| Andrew Isaacson | Senior Development | Profile | |
| Laetitia Cousin | Quality Affairs | Profile | |
| Carolyn Sleeth | Senior Manager | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Insulet. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Will Health Care Equipment & Supplies sector continue expanding? Could Insulet diversify its offerings? Factors like these will boost the valuation of Insulet. Anticipated expansion of Insulet directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Insulet data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.148 | Earnings Share 3.42 | Revenue Per Share | Quarterly Revenue Growth 0.299 | Return On Assets |
Understanding Insulet requires distinguishing between market price and book value, where the latter reflects Insulet's accounting equity. The concept of intrinsic value - what Insulet's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Insulet's price substantially above or below its fundamental value.
It's important to distinguish between Insulet's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Insulet should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Insulet's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.